Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization

• Published in: JACC. Cardiovascular interventions 2009-07, Vol.2 (7), p.614-621
• Main Authors: Frutkin, Andrew D., MD, Lindsey, Jason B., MD, Mehta, Sameer K., MD, House, John A., MS, Spertus, John A., MD, MPH, Cohen, David J., MD, MSc, Rumsfeld, John S., MD, PhD, Marso, Steven P., MD
• Format: Article
• Language: English
• Subjects: Cardiovascular; coronary artery bypass grafting; drug-eluting stents; percutaneous coronary intervention
• ISSN: 1936-8798; 1876-7605
• DOI: 10.1016/j.jcin.2009.05.001

Drug-Eluting Stents and the Use of Percutaneous Coronary Intervention Among Patients With Class I Indications for Coronary Artery Bypass Surgery Undergoing Index Revascularization: Analysis From the NCDR (National Cardiovascular Data Registry) Andrew D. Frutkin, Jason B. Lindsey, Sameer K. Mehta, John A. House, John A. Spertus, David J. Cohen, John S. Rumsfeld, Steven P. Marso, on behalf of the NCDR (National Cardiovascular Data) Registry We evaluated rates of attempted percutaneous coronary intervention (PCI) in patients with class I indications for coronary artery bypass grafting (CABG) before and after the availability of drug-eluting stents (DES) in clinical practice. In over 265,000 patients with class I indications from 299 centers participating in the NCDR (National Cardiovascular Data Registry), in-hospital CABG rates declined and attempted PCI increased in the years after the adoption of DES compared with the preceding time period. This association persisted after adjustment for patient and hospital characteristics. Long-term follow-up is needed to understand the implications of this trend.